MAGE-C2 TCR T Cell Trial to Treat Melanoma and Head and Neck Cancer
Conditions: Melanoma; Melanoma, Uveal; Head and Neck Cancer Intervention: Biological: Adoptive therapy with autologous MC2 TCR T cells Sponsors: Erasmus Medical Center; Ludwig Institute for Cancer Research; Dutch Cancer Society; Stichting Coolsingel Rotterdam grant; Jan Ivo Stichting grant Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Eye Cancers | Grants | Head and Neck Cancer | Melanoma | Research | Skin Cancer | Uveal Melanoma